Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides
- 1 March 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (5) , 749-754
- https://doi.org/10.1016/s0960-894x(99)00073-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 3-pyridylethanolamines: Potent and selective human β3 adrenergic receptor agonistsBioorganic & Medicinal Chemistry Letters, 1998
- 3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic propertiesBioorganic & Medicinal Chemistry Letters, 1998
- A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.Journal of Clinical Investigation, 1998
- Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1998
- Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptorBioorganic & Medicinal Chemistry Letters, 1998
- β3-adrenergic agonists: potential therapeutics for obesityExpert Opinion on Investigational Drugs, 1997
- BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITYAnnual Review of Medicine, 1997
- The potential role of β3 adrenoceptor agonists In the treatment of obesity and diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- Chapter 20. β3-Selective Adrenergic Receptor AgonistsPublished by Elsevier ,1995